Anuj Suri Download Headshot

Anuj Suri, MD, FACOG

  • Houston Methodist gynecologic oncologist
  • Assistant Professor of Clinical Obstetrics and Gynecology, Houston Methodist Institute for Academic Medicine
Media Contact: Daniel Brown , 832.667.5849

Anuj Suri, MD, FACOG

Request Interview
Media Contact: Daniel Brown , 832.667.5849

Areas of Expertise

  • Chemotherapy
  • Gynecologic surgery
  • Gynecological procedures
  • Laparoscopic cancer surgery
  • Robotic surgery
  • Vulvar & cervical pathology

Credentials

BOARD CERTIFICATION
American Board of Obstetrics and Gynecology | 2015
American Board of Gynecological Oncology | 2017
MEDICAL SCHOOL
Doctor of Medicine, University of Tennessee College of Medicine- Memphis, TN | 2006
RESIDENCY
The University of Texas Medical School at Houston - Houston, TX | 2010
FELLOWSHIP
Gynecologic Oncology - Chapel Hill, NC | 2013

Publications

Synchronous endometrial endometrioid adenocarcinoma and ovarian endometrioid adenocarcinoma
Rodríguez González, E, Deavers, M, Chang, S & Suri, A 2024, , International Journal of Gynecological Cancer, vol. 34, no. 2, pp. 332-338. https://doi.org/10.1136/ijgc-2023-005201

The association between progesterone receptor expression and survival in women with adult granulosa cell tumors
Puechl, AM, Edwards, J, Suri, A, Nakayama, J, Bean, S, Gehrig, P, Saks, E, Duska, L, Broadwater, G, Ehrisman, J, Horowitz, N & Secord, AA 2019, , Gynecologic oncology, vol. 153, no. 1, pp. 74-79. https://doi.org/10.1016/j.ygyno.2019.01.016

The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Suri, A, Sheng, X, Schuler, KM, Zhong, Y, Han, X, Jones, HM, Gehrig, PA, Zhou, C & Bae-Jump, VL 2016, , Oncotarget, vol. 7, no. 26, pp. 39582-39594. https://doi.org/10.18632/oncotarget.8659

Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors
Suri, A, Carter, EB, Horowitz, N, Denslow, S & Gehrig, PA 2013, , Gynecologic oncology, vol. 131, no. 2, pp. 321-324. https://doi.org/10.1016/j.ygyno.2013.08.013

Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumors
Stine, JE, Suri, A, Gehrig, PA, Chiu, M, Erickson, BK, Huh, WK, Soper, JT, Le, LV, Conner, MG & Kim, KH 2013, , Gynecologic oncology, vol. 131, no. 1, pp. 59-62. https://doi.org/10.1016/j.ygyno.2013.06.030

Minimally invasive surgery in endometrial cancer: Recent updates
Doll, KM, Suri, A & Gehrig, PA 2013, , Expert Review of Obstetrics and Gynecology, vol. 8, no. 3, pp. 271-283. https://doi.org/10.1586/eog.13.14

Discussion: 'Ovarian epithelial carcinoma with pelvic endometriosis,' by Wang et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Doll, K, Stine, J & Kim, K 2013, , American Journal of Obstetrics and Gynecology, vol. 208, no. 5, pp. e1-e2. https://doi.org/10.1016/j.ajog.2013.03.014

Ovarian epithelial carcinoma with pelvic endometriosis: Wang et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Doll, K, Stine, J & Kim, K 2013, , American Journal of Obstetrics and Gynecology, vol. 208, no. 5, pp. 415-416. https://doi.org/10.1016/j.ajog.2013.03.004

Surgical staging in early ovarian carcinoma: Garcia-Soto et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Kilgore, J, Ko, E, Gehrig, P & Brewster, W 2012, , American Journal of Obstetrics and Gynecology, vol. 206, no. 3, pp. 263-264. https://doi.org/10.1016/j.ajog.2012.01.019

Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et al
Van Le, L, Jackson, A, Schuler, K, Suri, A, Kilgore, J, Ko, E, Gehrig, P & Brewster, W 2012, , American Journal of Obstetrics and Gynecology, vol. 206, no. 3, pp. e1-e3. https://doi.org/10.1016/j.ajog.2012.01.020

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations missed opportunities
Meyer, LA, Anderson, ME, Lacour, RA, Suri, A, Daniels, MS, Urbauer, DL, Nogueras-Gonzalez, GM, Schmeler, KM, Gershenson, DM & Lu, KH 2010, , Obstetrical and Gynecological Survey, vol. 65, no. 7, pp. 436-437. https://doi.org/10.1097/OGX.0b013e3181e62f2d

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: Missed opportunities
Meyer, LA, Anderson, ME, Lacour, RA, Suri, A, Daniels, MS, Urbauer, DL, Nogueras-Gonzalez, GM, Schmeler, KM, Gershenson, DM & Lu, KH 2010, , Obstetrics and Gynecology, vol. 115, no. 5, pp. 945-952. https://doi.org/10.1097/AOG.0b013e3181da08d7

Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer
Suri, A, Frumovitz, M, Milam, MR, dos Reis, R & Ramirez, PT 2009, , Gynecologic oncology, vol. 112, no. 1, pp. 110-113. https://doi.org/10.1016/j.ygyno.2008.09.011

Languages

  • English